Amalgamated Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Amalgamated Financial’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$155K	Buy	+5,497	New	+$205K	﹤0.01%	1992

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Amalgamated Financial's ANIP Position: Q1 2022 in Review

Amalgamated Financial opened a new position in ANI Pharmaceuticals (ANIP) in Q1 2022: 5,497 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #1992 among its holdings.

126 funds tracked by Wall St. Rank hold ANIP as of Q1 2022.

Amalgamated Financial held 5,497 shares of ANI Pharmaceuticals worth $155K as of Q1 2022.
ANI Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
ANI Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1992 holding.
126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.